Skip to search formSkip to main contentSkip to account menu

Atosiban

Known as: 1-deamino-2-Tyr(OEt)-4-Thr-8-Orn-oxytocin, (Mpa(1)-D-Tyr(Et)(2)-Thr(4)-Orn(8))-oxytocin, 1-Deamino-2D-tyr-(OEt)-4-thr-8-orn-oxytocin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Twin gestation contributes significantly to perinatal morbidity and mortality related to high occurrence of preterm birth. We… 
2016
2016
The objective of this study was to investigate the clinical efficacy and adverse events of treatment with the oxytocin receptor… 
2014
2014
Common use of tocolytic drugs in preterm labor has not been shown to reduce the rate of neonatal mortality and morbidity… 
2009
2009
The molecular weights of unreduced and reduced for the disulfide bond in the atosiban were measured,and the primary structure of… 
2007
2007
The effect of peripherally administered oxytocin (OT) on gastric ischemia-reperfusion injury (GI-RI) and its possible mechanism… 
2002
2002
We analyzed the information available about the tocolytic drug atosiban to evaluate the advantages and disadvantages of this drug… 
2001
2001
Purpose: To evaluate the effects of Atosiban which has been recently made available for routine treatment of patients with… 
2001
2001
L'atosiban, premier representant d'une nouvelle famille d'agents tocolytiques, les antagonistes des recepteurs de l'ocytocine… 
1996
1996
We tested the hypothesis that increased oxytocin is a necessary mechanism for the mediation of androstenedione (delta 4A)-induced…